aims to revolutionize cardiovascular care with their innovative braiding technology and expert procedure planning. Founded in 1998, the company specializes in endovascular treatments for cardiovascular conditions and aortic dissection. Their latest investment of €6.00M from S.R.I.W. on 25 October 2022 underscores the confidence investors have in their cutting-edge solutions. Intressa Vascular's commitment to collaboration and open-mindedness drives the development of high-quality products, ultimately improving patient care in the Health Care industry.
No recent news or press coverage available for Intressa Vascular.